CASI Pharmaceuticals, Inc. (CASIF) Form 10-Q Quarterly Reports
CASI Pharmaceuticals, Inc. (CASIF) is a publicly traded company on the OTC, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: CASIF
CIK: 1962738
Exchange: OTC
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: E9
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
KPMG Huazhen LLP
Auditor SinceSince 12/31/2022 12:00:00 AM
Lead Engagement PartnerPu Wang
Audit LocationBeijing, China
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 6-K | 2026-09-02 | 2026-09-02 | FORM 6-K | 0001104659-26-104455 | View SEC Doc Filr Page |
| 6-K | 2026-08-14 | 2026-08-14 | FORM 6-K | 0001104659-26-096404 | View SEC Doc Filr Page |
| 6-K | 2026-08-13 | 2026-08-13 | FORM 6-K | 0001104659-26-095969 | View SEC Doc Filr Page |
| 6-K | 2026-07-15 | 2026-07-15 | FORM 6-K | 0001104659-26-083702 | View SEC Doc Filr Page |
| 6-K | 2026-06-29 | 2026-06-29 | FORM 6-K | 0001104659-26-078452 | View SEC Doc Filr Page |
| 25-NSE | 2026-06-23 | — | 25-NSE Filing | 0001354457-26-000606 | View SEC Doc Filr Page |
| 6-K | 2026-06-02 | 2026-06-02 | FORM 6-K | 0001104659-26-069177 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-05-18 | — | SCHEDULE 13D/A Filing | 0001104659-26-063233 | View SEC Doc Filr Page |
| 20-F | 2026-05-15 | 2025-12-31 | 20-F | 0001104659-26-061632 | View SEC Doc Filr Page |
| D | 2026-04-28 | — | D Filing | 0001962738-26-000004 | View SEC Doc Filr Page |
| 3 | 2026-04-23 | 2026-03-18 | OWNERSHIP DOCUMENT | 0001104659-26-047080 | View SEC Doc Filr Page |
| NT 20-F | 2026-04-21 | 2025-12-31 | NT 20-F | 0001104659-26-045634 | View SEC Doc Filr Page |
| 3 | 2026-04-20 | 2026-03-18 | OWNERSHIP DOCUMENT | 0001104659-26-045617 | View SEC Doc Filr Page |
| 6-K | 2026-04-20 | 2026-04-20 | FORM 6-K | 0001104659-26-045529 | View SEC Doc Filr Page |
| 6-K | 2026-04-20 | 2026-04-20 | FORM 6-K | 0001104659-26-045275 | View SEC Doc Filr Page |
| 3 | 2026-04-16 | 2026-03-18 | OWNERSHIP DOCUMENT | 0001104659-26-044404 | View SEC Doc Filr Page |
| 6-K | 2026-04-15 | 2026-04-15 | FORM 6-K | 0001104659-26-043516 | View SEC Doc Filr Page |
| 3 | 2026-04-13 | 2026-03-18 | OWNERSHIP DOCUMENT | 0001104659-26-042658 | View SEC Doc Filr Page |
| 3 | 2026-04-07 | 2026-03-18 | OWNERSHIP DOCUMENT | 0001104659-26-040417 | View SEC Doc Filr Page |
| 3 | 2026-04-03 | 2026-03-18 | OWNERSHIP DOCUMENT | 0001104659-26-039652 | View SEC Doc Filr Page |
| 3 | 2026-04-03 | 2026-03-18 | OWNERSHIP DOCUMENT | 0001104659-26-039647 | View SEC Doc Filr Page |
| 3 | 2026-03-27 | 2026-03-18 | OWNERSHIP DOCUMENT | 0001104659-26-035726 | View SEC Doc Filr Page |
| 3 | 2026-03-25 | 2026-03-18 | OWNERSHIP DOCUMENT | 0001104659-26-034136 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-03-23 | — | SCHEDULE 13D/A Filing | 0001104659-26-032956 | View SEC Doc Filr Page |
| 3 | 2026-03-18 | 2026-03-18 | OWNERSHIP DOCUMENT | 0001104659-26-031455 | View SEC Doc Filr Page |